| FUND | HOLDING | % OF FUND | VALUE ($) |
|---|---|---|---|
CURE | Eli Lilly and (LLY) | 11.705% | $16.8M |
CURE | Johnson & Johnson (JNJ) | 8.151% | $11.7M |
CURE | AbbVie (ABBV) | 5.475% | $7.9M |
CURE | UnitedHealth (UNH) | 5.319% | $7.7M |
CURE | Merck (MRK) | 4.219% | $6.1M |
CURE | Amgen (AMGN) | 2.711% | $3.9M |
CURE | Thermo Fisher Scientific (TMO) | 2.597% | $3.7M |
CURE | Gilead Sciences (GILD) | 2.53% | $3.6M |
CURE | Intuitive Surgical (ISRG) | 2.279% | $3.3M |
CURE | Pfizer (PFE) | 2.242% | $3.2M |
CURE | Abbott Laboratories (ABT) | 2.193% | $3.2M |
CURE | CVS Health (CVS) | 1.792% | $2.6M |
CURE | Bristol-Myers Squibb (BMY) | 1.732% | $2.5M |
CURE | Vertex Pharmaceuticals (VRTX) | 1.688% | $2.4M |
CURE | Danaher (DHR) | 1.6% | $2.3M |
CURE | Stryker (SYK) | 1.487% | $2.1M |
CURE | Medtronic (MDT) | 1.46% | $2.1M |
CURE | McKesson (MCK) | 1.357% | $2M |
CURE | Elevance Health (ELV) | 1.287% | $1.9M |
CURE | Boston Scientific (BSX) | 1.209% | $1.7M |
CURE | Cigna (CI) | 1.163% | $1.7M |
CURE | Regeneron Pharmaceuticals (REGN) | 1.097% | $1.6M |
CURE | HCA (HCA) | 1.02% | $1.5M |
CURE | CoreSite Realty (COR) | 0.772% | $1.1M |
CURE | Edwards Lifesciences (EW) | 0.684% | $984,186.81 |
Holdings are tracked for approximately 2000 ETFs.